Generation of Anti-c-Met Single Domain Antibody Fragment Based on Human Stable Frameworks

被引:0
作者
Edwardraja, Selvakumar [1 ,2 ]
Sokalingam, Sriram [1 ]
Raghunathan, Govindan [1 ]
Hwang, Bum-Yeol [3 ]
Lee, Sun-Gu [1 ]
机构
[1] Pusan Natl Univ, Dept Chem Engn, Pusan 609735, South Korea
[2] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA
[3] Univ Calif Berkeley, Dept Chem & Biomol Engn, Inst QB3, Berkeley, CA 94720 USA
关键词
antibody engineering; single domain antibody; CDR grafting; human stable framework; CHAIN FV ANTIBODY; ESCHERICHIA-COLI; VARIABLE DOMAINS; PROTEINS; STABILITY; THERAPY; SOLUBILITY; EXPRESSION; VH;
D O I
10.1007/s12257-012-0378-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The size reduction is an important issue in the biomedical application of antibody and single domain antibody fragment is recognized as very attractive tool. However, it is very time-consuming and laborious to generate the fragment antibody with targeted binding function. Here, we investigated the possibility to prepare single domain antibody (sdAb) by a simple grafting method based on stable human consensus framework sequences. The complementarity determining region sequences in V-H domain of anti-c-Met scFv from rabbit were grafted with the human V(H)3 consensus framework sequences, which generated the anti-c-Met single domain antibody showing almost same binding activity to its scFv form. The generated single domain antibody could be produced as functional form in oxidizing cytoplasm of E. coli, but produced as inactive form in reducing cytoplasm. The structural analysis of the homology models gave us the insight on the stability of the single domain antibody. In this report, we have demonstrated that the very stable human consensus framework sequence can be used for the generation of active anti-c-Met sdAb via complementarity determining regions grafting. We expect that this kind of grafting method for the generation of sdAb may provide us with the opportunities to prepare sdAbs based on the known antibody sequences.
引用
收藏
页码:1120 / 1127
页数:8
相关论文
共 24 条
  • [1] Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
    Baral, Toya Nath
    Magez, Stefan
    Stijlemans, Benoit
    Conrath, Katja
    Vanhollebeke, Benoit
    Pays, Etienne
    Muyldermans, Serge
    De Baetselier, Patrick
    [J]. NATURE MEDICINE, 2006, 12 (05) : 580 - 584
  • [2] Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains
    Barthelemy, Pierre A.
    Raab, Helga
    Appleton, Brent A.
    Bond, Christopher J.
    Wu, Ping
    Wiesmann, Christian
    Sidhu, Sachdev S.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (06) : 3639 - 3654
  • [3] Antigen binding and solubility effects upon veneering of a camel VHH in framework-2 to the mimic a VH
    Conrath, K
    Vincke, C
    Stijlemans, B
    Schymkowitz, J
    Decanniere, K
    Wyns, L
    Muyldermans, S
    Loris, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2005, 350 (01) : 112 - 125
  • [4] Efficient cancer therapy with a nanobody-based conjugate
    Cortez-Retamozo, V
    Backmann, N
    Senter, PD
    Wernery, U
    De Baetselier, P
    Muyldermans, S
    Revets, H
    [J]. CANCER RESEARCH, 2004, 64 (08) : 2853 - 2857
  • [5] ESBRI: A web server for evaluating salt bridges in proteins
    Costantini, Susan
    Colonna, Giovanni
    Facchiano, Angelo M.
    [J]. BIOINFORMATION, 2008, 3 (03) : 137 - 138
  • [6] Redesigning of Anti-c-Met Single Chain Fv Antibody for the Cytoplasmic Folding and Its Structural Analysis
    Edwardraja, Selvakumar
    Neelamegam, Rameshkumar
    Ramadoss, Vijayaraj
    Venkatesan, Subramanian
    Lee, Sun-Gu
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2010, 106 (03) : 367 - 375
  • [7] Biophysical properties of human antibody variable domains
    Ewert, S
    Huber, T
    Honegger, A
    Plückthun, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 325 (03) : 531 - 553
  • [8] Stability improvement of antibodies for extracellular and intracellular applications:: CDR grafting to stable frameworks and structure-based framework engineering
    Ewert, S
    Honegger, A
    Plückthun, A
    [J]. METHODS, 2004, 34 (02) : 184 - 199
  • [9] Prokaryotic expression of antibodies and affibodies
    Fernández, LA
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2004, 15 (04) : 364 - 373
  • [10] Engineered affinity proteins for tumour-targeting applications
    Friedman, Mikaela
    Stahl, Stefan
    [J]. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2009, 53 : 1 - 29